Cryoport Inc
CYRX5.460USD
-0.120-2.15%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
272.50MCap. mercado
PérdidaP/E TTM
Más Datos de Cryoport Inc Compañía
Cryoport, Inc. provides supply chain solutions for the Life Sciences with a focus on cell and gene therapies. The Company enables manufacturers, contract manufacturers, contract research organizations, developers, and researchers to carry out their respective business with products and services. It provides a range of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories.
Información de la empresa
Código de la empresaCYRX
Nombre de la empresaCryoport Inc
Fecha de salida a bolsaJul 24, 2015
Fundada en1990
Director ejecutivoMr. Jerrell Wilson (Jerry) Shelton
Número de empleados1090
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 24
Dirección112 Westwood Place, Suite 350
CiudadBRENTWOOD
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal37027
Teléfono19492321900
Sitio Webhttps://www.cryoport.com/
Código de la empresaCYRX
Fecha de salida a bolsaJul 24, 2015
Fundada en1990
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
706.97K
+3.89%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
27.38K
+88.35%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
26.43K
+94.55%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
11.96K
-17.29%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Richard J. Berman
Mr. Richard J. Berman
Lead Independent Director
Lead Independent Director
--
--
Mr. Ram M. Jagannath
Mr. Ram M. Jagannath
Independent Director
Independent Director
--
--
Mr. Scott Eckstein
Mr. Scott Eckstein
Investor Relations
Investor Relations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
706.97K
+3.89%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
27.38K
+88.35%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
26.43K
+94.55%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
11.96K
-17.29%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
BioLogistics solutions
138.63M
60.70%
Life Science products
74.72M
32.72%
BioStorage/Bioservices
15.03M
6.58%
Por regiónUSD
Nombre
Ganancia
Proporción
Americas
126.37M
55.33%
Europe & Middle East & Africa (EMEA)
59.60M
26.09%
Asia Pacific
42.42M
18.57%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
BioLogistics solutions
138.63M
60.70%
Life Science products
74.72M
32.72%
BioStorage/Bioservices
15.03M
6.58%
Accionista
Hora de actualización: dom., 23 de feb
Hora de actualización: dom., 23 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
Cadian Capital Management LP
9.83%
Morgan Stanley & Co. LLC
9.20%
Brown Capital Management, LLC
8.89%
Millennium Management LLC
8.26%
BlackRock Institutional Trust Company, N.A.
6.03%
Other
57.80%
Estadísticas de accionistas
Accionista
Proporción
Cadian Capital Management LP
9.83%
Morgan Stanley & Co. LLC
9.20%
Brown Capital Management, LLC
8.89%
Millennium Management LLC
8.26%
BlackRock Institutional Trust Company, N.A.
6.03%
Other
57.80%
Tipo
Accionista
Proporción
Investment Advisor
34.73%
Investment Advisor/Hedge Fund
27.63%
Hedge Fund
23.30%
Research Firm
10.71%
Individual Investor
2.75%
Pension Fund
2.55%
Sovereign Wealth Fund
0.70%
Private Equity
0.61%
Bank and Trust
0.15%
Participación institucional
Hora de actualización: lun., 3 de mar
Hora de actualización: lun., 3 de mar
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
394
51.74M
103.20%
-14.27M
2024Q4
407
51.87M
104.93%
-14.28M
2024Q3
422
52.00M
105.24%
-13.61M
2024Q2
423
53.55M
108.72%
-9.95M
2024Q1
437
55.31M
112.51%
-7.56M
2023Q4
468
54.03M
110.37%
-6.18M
2023Q3
482
49.41M
101.04%
-7.52M
2023Q2
492
49.81M
109.19%
-5.40M
2023Q1
500
48.02M
99.15%
-8.43M
2022Q4
513
48.06M
98.07%
-6.28M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Cadian Capital Management LP
4.93M
9.87%
+609.02K
+14.10%
Dec 31, 2024
Morgan Stanley & Co. LLC
4.61M
9.24%
+1.32K
+0.03%
Dec 31, 2024
Brown Capital Management, LLC
4.46M
8.93%
-692.65K
-13.45%
Dec 31, 2024
Millennium Management LLC
4.14M
8.29%
+409.35K
+10.97%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
3.02M
6.06%
-18.57K
-0.61%
Dec 31, 2024
The Vanguard Group, Inc.
2.73M
5.47%
-97.22K
-3.44%
Dec 31, 2024
Fred Alger Management, LLC
2.57M
5.14%
-131.83K
-4.88%
Dec 31, 2024
Natixis Investment Managers SA
1.71M
3.43%
--
--
Dec 31, 2024
DWS Investments UK Limited
1.40M
2.8%
+12.86K
+0.93%
Dec 31, 2024
New York State Common Retirement Fund
1.15M
2.3%
-37.55K
-3.17%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
Invesco NASDAQ Future Gen 200 ETF
0.4%
Inspire Small/Mid Cap ESG ETF
0.16%
JPMorgan Fundamental Data Science Small Core ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Invesco FTSE RAFI US 1500 Small-Mid ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Ver más
Invesco NASDAQ Future Gen 200 ETF
Proporción0.4%
Inspire Small/Mid Cap ESG ETF
Proporción0.16%
JPMorgan Fundamental Data Science Small Core ETF
Proporción0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.03%
Avantis US Small Cap Equity ETF
Proporción0.02%
Invesco FTSE RAFI US 1500 Small-Mid ETF
Proporción0.01%
Schwab U.S. Small-Cap ETF
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos